Should You Worry About Unibios Holdings S.A.’s (ATH:BIOSK) ROCE?

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card!

Today we’ll look at Unibios Holdings S.A. (ATH:BIOSK) and reflect on its potential as an investment. To be precise, we’ll consider its Return On Capital Employed (ROCE), as that will inform our view of the quality of the business.

Firstly, we’ll go over how we calculate ROCE. Then we’ll compare its ROCE to similar companies. Then we’ll determine how its current liabilities are affecting its ROCE.

What is Return On Capital Employed (ROCE)?

ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. In general, businesses with a higher ROCE are usually better quality. In brief, it is a useful tool, but it is not without drawbacks. Author Edwin Whiting says to be careful when comparing the ROCE of different businesses, since ‘No two businesses are exactly alike.’

So, How Do We Calculate ROCE?

The formula for calculating the return on capital employed is:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets – Current Liabilities)

Or for Unibios Holdings:

0.017 = -€60.3k ÷ (€22m – €9.0m) (Based on the trailing twelve months to June 2018.)

Therefore, Unibios Holdings has an ROCE of 1.7%.

View our latest analysis for Unibios Holdings

Does Unibios Holdings Have A Good ROCE?

ROCE is commonly used for comparing the performance of similar businesses. In this analysis, Unibios Holdings’s ROCE appears meaningfully below the 11% average reported by the Machinery industry. This performance could be negative if sustained, as it suggests the business may underperform its industry. Putting aside Unibios Holdings’s performance relative to its industry, its ROCE in absolute terms is poor – considering the risk of owning stocks compared to government bonds. It is likely that there are more attractive prospects out there.

ATSE:BIOSK Last Perf February 12th 19
ATSE:BIOSK Last Perf February 12th 19

When considering this metric, keep in mind that it is backwards looking, and not necessarily predictive. ROCE can be misleading for companies in cyclical industries, with returns looking impressive during the boom times, but very weak during the busts. This is because ROCE only looks at one year, instead of considering returns across a whole cycle. How cyclical is Unibios Holdings? You can see for yourself by looking at this free graph of past earnings, revenue and cash flow.

Do Unibios Holdings’s Current Liabilities Skew Its ROCE?

Current liabilities include invoices, such as supplier payments, short-term debt, or a tax bill, that need to be paid within 12 months. Due to the way the ROCE equation works, having large bills due in the near term can make it look as though a company has less capital employed, and thus a higher ROCE than usual. To check the impact of this, we calculate if a company has high current liabilities relative to its total assets.

Unibios Holdings has total liabilities of €9.0m and total assets of €22m. As a result, its current liabilities are equal to approximately 41% of its total assets. In light of sufficient current liabilities to noticeably boost the ROCE, Unibios Holdings’s ROCE is concerning.

What We Can Learn From Unibios Holdings’s ROCE

This company may not be the most attractive investment prospect. Of course, you might find a fantastic investment by looking at a few good candidates. So take a peek at this free list of companies with modest (or no) debt, trading on a P/E below 20.

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.